A Pilot Study of Blood-Based Predictive Biomarkers in Renal Cell Carcinoma

Summary

The purpose of this study is to collect blood and tumor tissue samples (when possible) from kidney cancer patients for various indicators of how their cancer is behaving in response to treatment. These indicators are referred to as biomarkers. A biomarker is a biological molecule found in blood, other body fluids, or tissues that may be a sign of a condition or disease. Biomarkers that will be studied include circulating tumor cells, circulating tumor DNA, and large oncosomes. Circulating tumor cells are rare cells in the bloodstream that have broken off from a tumor and could possibly lead to future metastases (spreading of cancer). The results of this pilot study will help determine whether it will be possible to conduct future studies that evaluate the use of blood biomarkers as a guide to clinical decision-making or monitoring treatment response for kidney cancer.


Inclusion Criteria

Not Available


Study Location(s)

Cedars-Sinai Cancer at SOCC


Full Title

A pilot study of blood-based predictive biomarkers in renal cell carcinoma

Details
Disease Type/Condition

Kidney

Principal Investigator

Posadas, Edwin

Co-Investigators

Howard Sandler, Hyung Kim, Kevin Scher, Robert Figlin, Timothy Daskivich

Age Group

Adult

Phase

N/A

IRB Number

Pro00043869


Contact
Email
cancer.trial.info@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Kidney

Principal Investigator

Posadas, Edwin

Age Group

Adult

Phase

N/A

IRB Number

IIT2016-03-POSADAS-PBRCC


Contact
Email
cancer.trial.info@cshs.org
Want to join the study or
learn more?